chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Excoriation, Fatigue, Haemoglobin, Headache, Hypoglycaemia
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 15 year old female with mole of skin who on 22-JUN-2007 was intramuscularly vaccinated with the first dose of GARDASIL (lot # 654272/0319U) in right arm. Secondary suspect therapy included hepatitis A vaccine (manufacturer unknown) and varicella virus vaccine live (manufacturer unknown). Concomitant therapy included MENACTRA and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid. The patient had strange itchy rash months before diagnosis, doctor recommended her taking CARITAN, did not diagnose. The patient also had DM (diabetes mellitus) Type 1 symptoms months before diagnosis. The following information was obtained through follow-up and/or provided by the government. On 29-OCT-2010 PCP (Primary Care Physician) records received for DOS (Date of Service) from 22-JUN-2007 to 12-AUG-2010. The patient returned on 12-SEP-2007 for additional vaccinations (reported to be second dose of GARDASIL, hepatitis A and varicella). PE (Physical exam) was WNL (Within Normal Limits). The third dose of GARDASIL and MENACTRA were administered on 21-MAR-2008. There was rash on feet and  legs for 1 week which was noted on 23-JUL-2008. Food allergy was questioned and the patient was sent for RAST (radioallergosorbent test). On 13-FEB-2009 the patient went to OV (office visit), MD (Doctor of Medicine) noted DM Type 1 dx (Diagnosis) was made in OCT-2008. The patient complained of headache (H/A). Rash was noted again on 12-AUG-2010. On 1-NOV-2010 ER (emergency room) records were received for DOS 10-SEP-2009. Final impression was as follow: Infectious Mononucleosis. Patient "c/c ST", running nose, vomiting, diarrhea, fatigue and HA for 1 week. Physical exam (PE) was positive for neck lymphadenopathy, abdominal tenderness, tender palpable spleen. D/c to f/u (Follow up) with PCP. On 8-NOV-2010 hospital records were received for DOS from 2-DEC-2009 to 6-SEP-2010 when patient presented at the ER after syncopal episode. Final impression was as follow: hypoglycemia, syncope. PE(+) was tenderness on upper extremities, abrasions on hands. On 6-SEP-2010 patient presented at ER with c/c abdominal pain, nausea, bloating, weakness. Patient left ER w/o (without) being discharged. A lot check has been initiated. One or more of the events required hospitalization, was considered to be disabling, was considered to be immediately life-threatening. This was originally reported by a consumer. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, and expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. No further information is available.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Infectious mononucleosis, Laboratory test abnormal, Lymphadenopathy, Nausea, Radioallergosorbent test
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 15 year old female with mole of skin who on 22-JUN-2007 was intramuscularly vaccinated with the first dose of GARDASIL (lot # 654272/0319U) in right arm. Secondary suspect therapy included hepatitis A vaccine (manufacturer unknown) and varicella virus vaccine live (manufacturer unknown). Concomitant therapy included MENACTRA and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid. The patient had strange itchy rash months before diagnosis, doctor recommended her taking CARITAN, did not diagnose. The patient also had DM (diabetes mellitus) Type 1 symptoms months before diagnosis. The following information was obtained through follow-up and/or provided by the government. On 29-OCT-2010 PCP (Primary Care Physician) records received for DOS (Date of Service) from 22-JUN-2007 to 12-AUG-2010. The patient returned on 12-SEP-2007 for additional vaccinations (reported to be second dose of GARDASIL, hepatitis A and varicella). PE (Physical exam) was WNL (Within Normal Limits). The third dose of GARDASIL and MENACTRA were administered on 21-MAR-2008. There was rash on feet and  legs for 1 week which was noted on 23-JUL-2008. Food allergy was questioned and the patient was sent for RAST (radioallergosorbent test). On 13-FEB-2009 the patient went to OV (office visit), MD (Doctor of Medicine) noted DM Type 1 dx (Diagnosis) was made in OCT-2008. The patient complained of headache (H/A). Rash was noted again on 12-AUG-2010. On 1-NOV-2010 ER (emergency room) records were received for DOS 10-SEP-2009. Final impression was as follow: Infectious Mononucleosis. Patient "c/c ST", running nose, vomiting, diarrhea, fatigue and HA for 1 week. Physical exam (PE) was positive for neck lymphadenopathy, abdominal tenderness, tender palpable spleen. D/c to f/u (Follow up) with PCP. On 8-NOV-2010 hospital records were received for DOS from 2-DEC-2009 to 6-SEP-2010 when patient presented at the ER after syncopal episode. Final impression was as follow: hypoglycemia, syncope. PE(+) was tenderness on upper extremities, abrasions on hands. On 6-SEP-2010 patient presented at ER with c/c abdominal pain, nausea, bloating, weakness. Patient left ER w/o (without) being discharged. A lot check has been initiated. One or more of the events required hospitalization, was considered to be disabling, was considered to be immediately life-threatening. This was originally reported by a consumer. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, and expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. No further information is available.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Rash, Rash pruritic, Rhinorrhoea, Spleen palpable, Syncope
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 15 year old female with mole of skin who on 22-JUN-2007 was intramuscularly vaccinated with the first dose of GARDASIL (lot # 654272/0319U) in right arm. Secondary suspect therapy included hepatitis A vaccine (manufacturer unknown) and varicella virus vaccine live (manufacturer unknown). Concomitant therapy included MENACTRA and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid. The patient had strange itchy rash months before diagnosis, doctor recommended her taking CARITAN, did not diagnose. The patient also had DM (diabetes mellitus) Type 1 symptoms months before diagnosis. The following information was obtained through follow-up and/or provided by the government. On 29-OCT-2010 PCP (Primary Care Physician) records received for DOS (Date of Service) from 22-JUN-2007 to 12-AUG-2010. The patient returned on 12-SEP-2007 for additional vaccinations (reported to be second dose of GARDASIL, hepatitis A and varicella). PE (Physical exam) was WNL (Within Normal Limits). The third dose of GARDASIL and MENACTRA were administered on 21-MAR-2008. There was rash on feet and  legs for 1 week which was noted on 23-JUL-2008. Food allergy was questioned and the patient was sent for RAST (radioallergosorbent test). On 13-FEB-2009 the patient went to OV (office visit), MD (Doctor of Medicine) noted DM Type 1 dx (Diagnosis) was made in OCT-2008. The patient complained of headache (H/A). Rash was noted again on 12-AUG-2010. On 1-NOV-2010 ER (emergency room) records were received for DOS 10-SEP-2009. Final impression was as follow: Infectious Mononucleosis. Patient "c/c ST", running nose, vomiting, diarrhea, fatigue and HA for 1 week. Physical exam (PE) was positive for neck lymphadenopathy, abdominal tenderness, tender palpable spleen. D/c to f/u (Follow up) with PCP. On 8-NOV-2010 hospital records were received for DOS from 2-DEC-2009 to 6-SEP-2010 when patient presented at the ER after syncopal episode. Final impression was as follow: hypoglycemia, syncope. PE(+) was tenderness on upper extremities, abrasions on hands. On 6-SEP-2010 patient presented at ER with c/c abdominal pain, nausea, bloating, weakness. Patient left ER w/o (without) being discharged. A lot check has been initiated. One or more of the events required hospitalization, was considered to be disabling, was considered to be immediately life-threatening. This was originally reported by a consumer. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, and expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. No further information is available.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Type 1 diabetes mellitus, Vomiting
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 15 year old female with mole of skin who on 22-JUN-2007 was intramuscularly vaccinated with the first dose of GARDASIL (lot # 654272/0319U) in right arm. Secondary suspect therapy included hepatitis A vaccine (manufacturer unknown) and varicella virus vaccine live (manufacturer unknown). Concomitant therapy included MENACTRA and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid. The patient had strange itchy rash months before diagnosis, doctor recommended her taking CARITAN, did not diagnose. The patient also had DM (diabetes mellitus) Type 1 symptoms months before diagnosis. The following information was obtained through follow-up and/or provided by the government. On 29-OCT-2010 PCP (Primary Care Physician) records received for DOS (Date of Service) from 22-JUN-2007 to 12-AUG-2010. The patient returned on 12-SEP-2007 for additional vaccinations (reported to be second dose of GARDASIL, hepatitis A and varicella). PE (Physical exam) was WNL (Within Normal Limits). The third dose of GARDASIL and MENACTRA were administered on 21-MAR-2008. There was rash on feet and  legs for 1 week which was noted on 23-JUL-2008. Food allergy was questioned and the patient was sent for RAST (radioallergosorbent test). On 13-FEB-2009 the patient went to OV (office visit), MD (Doctor of Medicine) noted DM Type 1 dx (Diagnosis) was made in OCT-2008. The patient complained of headache (H/A). Rash was noted again on 12-AUG-2010. On 1-NOV-2010 ER (emergency room) records were received for DOS 10-SEP-2009. Final impression was as follow: Infectious Mononucleosis. Patient "c/c ST", running nose, vomiting, diarrhea, fatigue and HA for 1 week. Physical exam (PE) was positive for neck lymphadenopathy, abdominal tenderness, tender palpable spleen. D/c to f/u (Follow up) with PCP. On 8-NOV-2010 hospital records were received for DOS from 2-DEC-2009 to 6-SEP-2010 when patient presented at the ER after syncopal episode. Final impression was as follow: hypoglycemia, syncope. PE(+) was tenderness on upper extremities, abrasions on hands. On 6-SEP-2010 patient presented at ER with c/c abdominal pain, nausea, bloating, weakness. Patient left ER w/o (without) being discharged. A lot check has been initiated. One or more of the events required hospitalization, was considered to be disabling, was considered to be immediately life-threatening. This was originally reported by a consumer. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, and expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. No further information is available.
Age: 19.0
Sex: F
Vaccine: HEP
Symptoms: Injection site papule, Injection site urticaria
Clinical narrative: Pt has cold like symptoms at time of vaccination. 4 x 1 1/2 cm, wheal, posterior, left arm and small papules, left shoulder, no SOB or choking. Q10 Date of vaccination: Invalid date/time entry. Q11 Date Adverse Event: Invalid date/time entry.
Age: 1.66
Sex: M
Vaccine: DTAP, HIBV, DTAP, HIBV
Symptoms: Body temperature increased, Convulsion, Injection site erythema, Injection site induration, Injection site pruritus
Clinical narrative: Febrile seizure - simple - on 1-3-11. Temp and croup developed over ensuing 24 hrs from 1-3 -> 1-4-11.
Age: 1.66
Sex: M
Vaccine: DTAP, HIBV, DTAP, HIBV
Symptoms: Injection site swelling, Injection site warmth, Respiratory arrest
Clinical narrative: Febrile seizure - simple - on 1-3-11. Temp and croup developed over ensuing 24 hrs from 1-3 -> 1-4-11.
Age: 1.66
Sex: M
Vaccine: DTAP, HIBV, DTAP, HIBV
Symptoms: Chest X-ray abnormal, Croup infectious, Febrile convulsion
Clinical narrative: Febrile seizure - simple - on 1-3-11. Temp and croup developed over ensuing 24 hrs from 1-3 -> 1-4-11.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pruritus, Injection site swelling
Clinical narrative: ITCHING, SWELLING, RAISED ABOUT 1 INCH AT THE SITE AND ABOUT THE SIZE OF AND EGG CUT IN HALF
Age: 1.51
Sex: F
Vaccine: DTAP, HEPA, HIBV, PNC13
Symptoms: Cough, Croup infectious, Dyspnoea, Gaze palsy, Loss of consciousness
Clinical narrative: Patient had possible seizure. Patient had fever, eyes rolled back and then passed out for >30 seconds.  Patient then had some dyspnea and a croupy cough.
Age: 1.51
Sex: F
Vaccine: DTAP, HEPA, HIBV, PNC13
Symptoms: Pyrexia
Clinical narrative: Patient had possible seizure. Patient had fever, eyes rolled back and then passed out for >30 seconds.  Patient then had some dyspnea and a croupy cough.
Age: 1.28
Sex: F
Vaccine: MMR
Symptoms: Aphasia, Autism spectrum disorder, Blood test, Fall, Gait disturbance
Clinical narrative: Four days after injection patient became pale and lethargic - she kept falling and her arms couldn't hold her from hitting the floor.  Then on the 7th/8th day she got a fever of 104.6 - we put her in the bath and it rocketed down to 93.2. The doctor on call sent her to the ER where they took blood and said her platelets were so low she prob had leukemia - she didn't - it was from the vaccine and eventually her platelets went back up. But she stopped speaking, sleeping, walking straight and was quickly diagnosed as on the Autism spectrum.
Age: 1.28
Sex: F
Vaccine: MMR
Symptoms: Insomnia, Lethargy, Pallor, Platelet count decreased, Pyrexia
Clinical narrative: Four days after injection patient became pale and lethargic - she kept falling and her arms couldn't hold her from hitting the floor.  Then on the 7th/8th day she got a fever of 104.6 - we put her in the bath and it rocketed down to 93.2. The doctor on call sent her to the ER where they took blood and said her platelets were so low she prob had leukemia - she didn't - it was from the vaccine and eventually her platelets went back up. But she stopped speaking, sleeping, walking straight and was quickly diagnosed as on the Autism spectrum.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Induration, Injection site pain, Injection site swelling, Joint range of motion decreased, Oedema peripheral
Clinical narrative: Onset of moderate-severe arm pain at site of injection. (Left deltoid) within 2 hours progressed to sense of swelling shoulder to fingertips left arm. Limited range of motion (L) shoulder (lateral and anterior movement). 2inch diameter induration without erythema.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Arm pain since received flu vaccination.
Sex: F
Vaccine: FLUX, PPV
Symptoms: Drug administered at inappropriate site, Feeling abnormal, Mobility decreased, Pain in extremity
Clinical narrative: I got my shots at the county offices that night I had so much pain in my right arm I couldn't use it. I was so out of it I thought it would go away, it didn't I went to my doctor. She gave me an anti inflammatory shot & pain pill. I did not go to my follow up, since my insurance wasn't active. The woman that gave me the shot would not file a report. So I do know the manufacturer or anything. My arm still hurts. I think all reactions should be reported. The nurse that gave me the shot gave it too high and she didn't seem to give a crap.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV, TDAP
Symptoms: Contusion, Oedema peripheral, Pain in extremity
Clinical narrative: Patient got bruises, swollen and pain on her arm.
Age: 0.57
Sex: F
Vaccine: DTAPIPVHIB, HEP, HIBV, RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Pt was administered a PENTACEL (DTAP, Polio, HIB) and a HIB vaccine at the same time. Pt showed no reaction.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HEPA
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Left arm swollen, red & painful from injection site down to elbow.
Age: 48.0
Sex: F
Vaccine: HEPA, TDAP
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: No reaction at this time gave 2 TDAP vaccines.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Oral herpes
Clinical narrative: Received shingles vacc. mid Dec - approx 8-10 days following got herpes type sore top of mouth (ck by dentist) now approx 2wks post last herpes sore had cold sore (herpes) sore on lip (before vacc - never had a cold sore or herpes sore in lifetime except child chicken pox.
Age: 37.0
Sex: F
Vaccine: ANTH
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Pt experienced redness, soreness, and warmth to the touch at the site.
Age: 45.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Injection site pain, Injection site swelling
Clinical narrative: Received MMR #1 12/13/10, right deltoid 1/3/11 Rt arm swelling began 1/3/11 with joint pain in elbow, wrist & hand. No shoulder pain, only Rt upper extremity. Is right hand dominant. 5 x 5 cm area at fleshy area of triceps tender to touch.
Age: 2.0
Sex: F
Vaccine: DTAP, FLU3, PNC13
Symptoms: Headache, Injection site erythema, Injection site swelling, Nausea, Pyrexia
Clinical narrative: Mom came back to facility on 1/14/11 with child and related the events that began after the immunizations received 1/11/11.  Mom states child ran a fever during the night after shots, no thermometer in home, Mom gave Ibuprofen and fever came down. During the day of 1/12/11 fever went up twice and brought down by Ibuprofen.  Mom states child also complained of headache and nausea.  Mom states legs were red and swollen at site of injections. Fever again on 1/13/11 and early in the morning of 1/14/11.  Mom states child to MD on 1/13/11 to follow-up on earwax and red eye problem-MD was aware of fever after vaccines but no fever at the MD appt and they were not concerned.  Child today temp is 96.8 by ear, no redness or swelling at injection sites, acting normally on visit playing with sticker, Mom states ate breakfast.  PHN again discussed side effects of vaccines, gave VIS's again.  Instructions to Mom to call MD if temp increases, headache gets worse or other symptoms increase.
Age: 57.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site erythema, Injection site infection, Injection site inflammation, Injection site warmth, Oedema peripheral
Clinical narrative: My arm began to itch and swell.  It became red and inflamed at the injection and around the injection site, extending to my elbow and whole upper arm.  It was hot to the touch. I contacted the doctor's office on Wednesday, January 12, 2011 and was advised to to take Benadryl and apply cold compresses.  When I woke up the next morning, it was worse.  I contacted the doctor again and requested an appointment.  The doctor said that it looked infected and prescribed Cephalexin (500 mg), 30 tablets and MethylPREDIsolone (4mg), 21 tablets. I started taking the medications on January 13, 2011.
Age: 57.0
Sex: F
Vaccine: FLUX
Symptoms: Pruritus
Clinical narrative: My arm began to itch and swell.  It became red and inflamed at the injection and around the injection site, extending to my elbow and whole upper arm.  It was hot to the touch. I contacted the doctor's office on Wednesday, January 12, 2011 and was advised to to take Benadryl and apply cold compresses.  When I woke up the next morning, it was worse.  I contacted the doctor again and requested an appointment.  The doctor said that it looked infected and prescribed Cephalexin (500 mg), 30 tablets and MethylPREDIsolone (4mg), 21 tablets. I started taking the medications on January 13, 2011.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Skin warm
Clinical narrative: 9 x 9 cm erythematous reaction occurred about 24 hrs after DTAP/IPV given. Quite warm to palpation.
Age: 2.0
Sex: M
Vaccine: HEPA, PNC13
Symptoms: Local reaction
Clinical narrative: Large local reaction - ice and antibiotic.
Age: 22.0
Sex: F
Vaccine: HEPAB, MMR, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site vesicles, Rash macular, Vaccination complication
Clinical narrative: 1/3/2011 received TST, TDAP, TWINRIX, MMR, Varicella. Pt. stated & observed to have macular rash in inner elbow region with some scratch marks she stated she had an allergy to the vaccinations returned 1/6/2011 for interpretation of TST . Around each area of injection were 1mm vesicles.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Redness around injection site and larger than a quarter.
Age: 24.0
Sex: F
Vaccine: TDAP
Symptoms: Eye irritation, Oedema peripheral, Pain, Rash macular, Swelling face
Clinical narrative: Left-eye burning and had blotches under my eye. Went to sleep and after an hour whole face was swollen and had pain all over my body and had swelling of hands & feet, prescribed steroids and BENADRYL.
Age: 70.0
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Develop redness around injection site size of baseball. It has reduced in 24 hours.
Age: 3.0
Sex: M
Vaccine: PNC13
Symptoms: Abnormal behaviour, Aggression, Mood altered
Clinical narrative: Mom reports pt had 3 days of being completely out of control, moody and violent. Denied fever or any other symptoms. OK after events.
Age: 0.18
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Rash generalised
Clinical narrative: Full body rash about 2 hrs after vaccine administration. No shortness of breath. Pt. referred to ER. Treatment unknown.
Age: 0.15
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV1, RV1, UNK, DTAPIPVHIB, HEP, PNC, RV1
Symptoms: Death, Irritability, Somnolence
Clinical narrative: Day after vaccines pt. sleepy, fussy. Two days after vaccines pt died.
Age: 0.15
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV1, RV1, UNK, DTAPIPVHIB, HEP, PNC, RV1
Symptoms: Death
Clinical narrative: Day after vaccines pt. sleepy, fussy. Two days after vaccines pt died.
Sex: F
Vaccine: HPV4
Symptoms: Activities of daily living impaired, Autonomic nervous system imbalance, Fatigue, Gastric disorder, Orthostatic hypotension
Clinical narrative: Information has been received from a physical therapist concerning three female patients who on an unspecified date were vaccinated with a dose of GARDASIL (lot# not reported). It was reported that on an unspecified date, the patients were suffering from dysautonomia. At the time of the report, the patients' outcomes were unknown. It was unknown if the patient sought medical attention. Follow up information has been received from the physical therapist concerning a current 13 year old female patient who developed orthostatic hypotension, tachycardia, "tummy trouble", fainting, and chronic fatigue after she received GARDASIL (lot and date unknown). She did not go to school for long periods of time because of these symptoms. The physical therapist stated that this condition has been "life altering". At the time of this report, the patient's outcome was unknown. Orthostatic hypotension, tachycardia, "tummy trouble", fainting and chronic fatigue were considered to be disabling. This is one of several reports received from the same source. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Syncope, Tachycardia
Clinical narrative: Information has been received from a physical therapist concerning three female patients who on an unspecified date were vaccinated with a dose of GARDASIL (lot# not reported). It was reported that on an unspecified date, the patients were suffering from dysautonomia. At the time of the report, the patients' outcomes were unknown. It was unknown if the patient sought medical attention. Follow up information has been received from the physical therapist concerning a current 13 year old female patient who developed orthostatic hypotension, tachycardia, "tummy trouble", fainting, and chronic fatigue after she received GARDASIL (lot and date unknown). She did not go to school for long periods of time because of these symptoms. The physical therapist stated that this condition has been "life altering". At the time of this report, the patient's outcome was unknown. Orthostatic hypotension, tachycardia, "tummy trouble", fainting and chronic fatigue were considered to be disabling. This is one of several reports received from the same source. No further information is available.
Age: 25.0
Sex: F
Vaccine: HPV4
Symptoms: Abortion spontaneous, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received from a 25 year old female consumer with allergy to penicillin and a history of leukemia, for the Pregnancy Registry for GARDASIL, who on 18-NOV-2009 was vaccinated with a first 0.5 ml dose of GARDASIL (Lot No. not reported). There was no concomitant medication. The consumer became pregnant after receiving her first dose of GARDASIL. Pregnancy was confirmed through a "home pregnancy test". Her LMP was on 11-NOV-2009 and her EDD was estimated to be on 18-AUG-2010. There was no adverse event reported. Follow up information has been received from a receptionist in the physician's office concerning the female patient. It was reported that the patient was pregnant and miscarried on 24-FEB-2010 at 11 weeks of gestation. Upon internal review the patient's miscarriage was considered to be another important medical event. The patient subsequently became pregnant again after vaccination with GARDASIL (MSD, WAES# 1101USA00792). Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, FLU3
Symptoms: Injection site erythema, Injection site induration, Local reaction
Clinical narrative: Local reaction to upper lf deltoid, red, 3 1/2" x 2" induration
Age: 41.0
Sex: M
Vaccine: FLU3, JEV
Symptoms: Unevaluable event
Clinical narrative: Pt was administered first series of Ixairio B on 27 Aug 2010. Pt presented to Immunizations Clinic while on a temporary duty and recieved JE-Vax on 11/15/2010. Due to the mixing of vaccines, Vaccine help hotline was called who inturn called their on-call doctor. On-call doc will return our call after doing further research.
Age: 58.0
Sex: M
Vaccine: PPV
Symptoms: Oedema peripheral, Pain in extremity, Skin warm
Clinical narrative: Patient called primary care provider (PCP) on 11/3/10 regarding swollen arm, painful to touch, and warm to touch. Patient instructed to use cold compress and analgesic of choice. Appointment to see patient scheduled for 11/4/10. Patient seen by PCP on 11/4/10. MD noted left arm swelling (but better today).
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: REDNESS AND SWELLING AT THE SITE OF INJECTION. OVAL AREA OF ERYTHEMA MEASURING 9X12 CM ON RIGHT THIGH SEEN TODAY.
Age: 29.0
Sex: F
Vaccine: ANTH
Symptoms: Oedema, Pruritus, Skin warm, Swelling
Clinical narrative: ITCHING, SWELLING, EDEMA, HOT  TREATED WITH SEPTRA DS FOR 14 DAYS
Age: 36.0
Sex: F
Vaccine: TDAP
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Severe pain and limited motion in in left arm following tetanus shot. Arm could not be extended above head from 12/31 until 1/8. This resulted in another visit to clinic on 1/7. At this time a medrol dose pack and ultrasound therapy were administered. Symtoms were alleviated on 1/8/10.
Age: 1.26
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Autoimmune thrombocytopenia, Platelet count decreased
Clinical narrative: Acute Immune thrombocytopenia purpura (ITP)
Age: 1.27
Sex: F
Vaccine: HIBV, MMR
Symptoms: Blood bicarbonate decreased, Blood chloride normal, Blood creatinine normal, Blood glucose increased, Blood potassium increased
Clinical narrative: Soaking through 10+ diapers per day, drinking a lot more, more lethargic. Admitted to Hospital with diabetic ketoacidosis and diagnosed with new onset insulin-dependent diabetes mellitus.
Age: 1.27
Sex: F
Vaccine: HIBV, MMR
Symptoms: Blood sodium decreased, Blood urea increased, Diabetic ketoacidosis, Lethargy, Pollakiuria
Clinical narrative: Soaking through 10+ diapers per day, drinking a lot more, more lethargic. Admitted to Hospital with diabetic ketoacidosis and diagnosed with new onset insulin-dependent diabetes mellitus.
Age: 1.27
Sex: F
Vaccine: HIBV, MMR
Symptoms: Polydipsia, Type 1 diabetes mellitus, Urine output increased
Clinical narrative: Soaking through 10+ diapers per day, drinking a lot more, more lethargic. Admitted to Hospital with diabetic ketoacidosis and diagnosed with new onset insulin-dependent diabetes mellitus.
Age: 0.47
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Convulsion, Diarrhoea, Dyskinesia, Electroencephalogram abnormal, Encephalopathy
Clinical narrative: This female subject was enrolled in the study 112957 (HIB-097). On 21 July 2010 and 17 September 2010, she received the 1st and 2nd dose of HIBERIX, IM R thigh), PEDIARIX, IM L thigh, Wyeth's PREVNAR 13, IM L thigh or deltoid and ROTARIX, PO. On 17 November 2010, she received a 3rd dose of HIBERIX, PEDIARIX and PREVNAR 13. This subject received HIBERIX lot number AHIBVC251A@ADO2VB363A. The subject's past medical history included gastroenteritis. On 20 November 2010, three days after the 3rd dose of HIBERIX, three days after 3rd dose of PEDIARIX, three days after the 3rd dose of PREVNAR 13, 64 days after the 2nd dose of ROTARIX, this five-month-old subject experienced seizure. The event was clinically significant (or requiring intervention). This seizure resolved with sequelae on 21 November 2010. On 25 December 2010, she experienced an other seizure. The event was clinically significant (or requiring intervention). This second seizure resolved with sequelae on 26 December 2010. The investigator considered that there was a reasonable possibility that the seizure may have been caused by HIBERIX, PEDIARIX, PREVNAR 13 and ROTARIX and that the events were possibly due to medical condition (gastroenteritis). Subsequent study vaccine administration was discontinued. The subject was withdrawn from the study due to the SAE. 30Dec2010 Electroencephalogram abnormal. Nov 17, 2010-Dose  3 of HIBERIX administered with concomitant vaccines PEDIARIX and PREVNAR 13. Nov 2010-Day 3 post vaccine-"Body jerking" first noted by parent awake and sleeping. Subject also diarrhea stool at each body jerking episode. Nov 21, 2010-Day 4 post vaccine-parent noted "body jerking" six times at two minutes intervals. Dec. 13, 2010-Clinic visit with MD for gastroenteritis and report of "glassy eyed" on 2 occasions. Dec. 30, 2010-EEG performed with outcome as follows: EEG tracing recorded in wake, sleep and drowsy was abnormal due to focal slowing and focal sharp wave activity. The tracing is suggestive of focal encephalopathy. Recommendation from Neurologist-clinical correlation and neuro imaging study. Jan 4 2011-Clinic visit with MD to discuss seizure and start of medications KEPPRA 10mg/kg bid. MRI ordered (apt pending) Neuro consult pending. Jan 4, 2011-Subject withdrawn from study per PI.
Age: 0.47
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Gastroenteritis, Muscle twitching, Staring
Clinical narrative: This female subject was enrolled in the study 112957 (HIB-097). On 21 July 2010 and 17 September 2010, she received the 1st and 2nd dose of HIBERIX, IM R thigh), PEDIARIX, IM L thigh, Wyeth's PREVNAR 13, IM L thigh or deltoid and ROTARIX, PO. On 17 November 2010, she received a 3rd dose of HIBERIX, PEDIARIX and PREVNAR 13. This subject received HIBERIX lot number AHIBVC251A@ADO2VB363A. The subject's past medical history included gastroenteritis. On 20 November 2010, three days after the 3rd dose of HIBERIX, three days after 3rd dose of PEDIARIX, three days after the 3rd dose of PREVNAR 13, 64 days after the 2nd dose of ROTARIX, this five-month-old subject experienced seizure. The event was clinically significant (or requiring intervention). This seizure resolved with sequelae on 21 November 2010. On 25 December 2010, she experienced an other seizure. The event was clinically significant (or requiring intervention). This second seizure resolved with sequelae on 26 December 2010. The investigator considered that there was a reasonable possibility that the seizure may have been caused by HIBERIX, PEDIARIX, PREVNAR 13 and ROTARIX and that the events were possibly due to medical condition (gastroenteritis). Subsequent study vaccine administration was discontinued. The subject was withdrawn from the study due to the SAE. 30Dec2010 Electroencephalogram abnormal. Nov 17, 2010-Dose  3 of HIBERIX administered with concomitant vaccines PEDIARIX and PREVNAR 13. Nov 2010-Day 3 post vaccine-"Body jerking" first noted by parent awake and sleeping. Subject also diarrhea stool at each body jerking episode. Nov 21, 2010-Day 4 post vaccine-parent noted "body jerking" six times at two minutes intervals. Dec. 13, 2010-Clinic visit with MD for gastroenteritis and report of "glassy eyed" on 2 occasions. Dec. 30, 2010-EEG performed with outcome as follows: EEG tracing recorded in wake, sleep and drowsy was abnormal due to focal slowing and focal sharp wave activity. The tracing is suggestive of focal encephalopathy. Recommendation from Neurologist-clinical correlation and neuro imaging study. Jan 4 2011-Clinic visit with MD to discuss seizure and start of medications KEPPRA 10mg/kg bid. MRI ordered (apt pending) Neuro consult pending. Jan 4, 2011-Subject withdrawn from study per PI.
Age: 13.0
Sex: M
Vaccine: DTP, PPV
Symptoms: Dizziness, Headache, Palpitations, Pyrexia
Clinical narrative: Fever 102.5 with severe headache, and fast pounding heart rate (did not think to take pulse at the time) fever lasted two days with headache dizziness and fast heartrate.
Age: 42.0
Sex: M
Vaccine: FLU3
Symptoms: Rash pruritic
Clinical narrative: extensive pruritic rash 2 hours after getting injection
Age: 20.0
Sex: M
Vaccine: FLU3, TDAP, TYP
Symptoms: Lymphadenopathy
Clinical narrative: When pt. awoke, he noticed swelling of his left axilla lymph node and left anterior cervical lymph node. Pt. took Tylenol for some relief of swelling. No fever or malaise. Swelling gone at 6 days.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Injection site pain, Pain
Clinical narrative: Some aches, mild dizziness, site soreness
Age: 0.36
Sex: F
Vaccine: HIBV
Symptoms: Crying, Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Localized swollen hard red area around injection site and unconsolable crying for 24 hours, would not open eyes just cried constantly.
Age: 60.0
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia, Flushing, Gait disturbance, Massage, Myalgia
Clinical narrative: Fever, faced flushed, joint aches, esp between rt hip and need, started in thigh muscle but by next day moved to nerve.  Made it hard to walk had to take pain meds to be able to walk.  Still having problems today. Went to a massage therapy session.  Nurse said it was prob. just a coincidence.
Age: 60.0
Sex: F
Vaccine: FLUX
Symptoms: Neuralgia, Pyrexia
Clinical narrative: Fever, faced flushed, joint aches, esp between rt hip and need, started in thigh muscle but by next day moved to nerve.  Made it hard to walk had to take pain meds to be able to walk.  Still having problems today. Went to a massage therapy session.  Nurse said it was prob. just a coincidence.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea
Clinical narrative: Violent nausea which was also reported in her friend that got the vaccine on the same night.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Vomiting
Clinical narrative: Violent vomiting at the same time as her friend who got the shot at the same time.
Age: 15.0
Sex: M
Vaccine: HPV4
Symptoms: Lip swelling, Oedema peripheral, Urticaria
Clinical narrative: Rash, urticarial maternal report of lip and extremity swelling.
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site reaction, Myalgia
Clinical narrative: Pt. complained of muscle pain in vaccinated arm/in area of bone radiating from elbow to shoulder on 1/10/11 advised to ice area take anti-inflammatory 1/12/11 reported much better only dull 1/14/11 much better - very slight. MD will follow.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Erythema, Injection site pain, Pain in extremity, Pruritus
Clinical narrative: 2 days after shot, injection site & arm ached. Then started to itch. Noticed 1 or 2 bumps/blisters started aching more. Blistery/rash area golf ball size with tennis ball size redness. Totally resolved in approx 10 days.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: 2 days after shot, injection site & arm ached. Then started to itch. Noticed 1 or 2 bumps/blisters started aching more. Blistery/rash area golf ball size with tennis ball size redness. Totally resolved in approx 10 days.
Age: 1.26
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Diarrhoea, Febrile convulsion, Occult blood negative, Pyrexia, Rash
Clinical narrative: Approximately 12 days s/p vaccines patient developed fever approximately 104 & associated febrile seizure. Rash noted next day with diarrhea.
Age: 18.0
Sex: F
Vaccine: TDAP, VARCEL
Symptoms: Injection site erythema, Injection site mass, Injection site pruritus, Rash erythematous, Rash pruritic
Clinical narrative: Two days after receiving varicella and TDAP developed "red, raised, itchy bumps about 10 cent size on back & arms. Red lump, itchy size of walnut to vaccine site". Denied SOB - Lump to arm dev. 1 day after immun.
Age: 26.0
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Convulsion
Clinical narrative: Seizure.
Age: 26.0
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Blood test, Computerised tomogram, Grand mal convulsion, Injection site pain
Clinical narrative: Seizure.
Age: 26.0
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Blood test normal, Bruxism, Computerised tomogram normal, Dyspnoea, Gaze palsy
Clinical narrative: Seizure.
Age: 26.0
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Grand mal convulsion, Injection site pain, Nuclear magnetic resonance imaging, Tongue biting, Unresponsive to stimuli
Clinical narrative: Seizure.
Age: 26.0
Sex: F
Vaccine: TDAP, TDAP, TDAP
Symptoms: Urine analysis normal
Clinical narrative: Seizure.
Age: 69.0
Sex: F
Vaccine: UNK
Symptoms: Pyrexia, Rash, Swelling
Clinical narrative: Febrile illness, rash, swelling.
Age: 2.0
Sex: M
Vaccine: FLUN3
Symptoms: Crying, Decreased appetite, Irritability, Lethargy, Ocular hyperaemia
Clinical narrative: Fever 102 degrees F Sore throat Weight loss Anorexia Red eyes Lethargy Crying Irritability
Age: 2.0
Sex: M
Vaccine: FLUN3
Symptoms: Oropharyngeal pain, Pyrexia, Streptococcus test negative, Weight decreased
Clinical narrative: Fever 102 degrees F Sore throat Weight loss Anorexia Red eyes Lethargy Crying Irritability
Age: 1.27
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Decreased appetite, Pyrexia, Rash erythematous, Rash generalised, Rash morbilliform
Clinical narrative: Child had high fever (104) for 1 day and lower fever the following day. On the second day of fever the child developed a rash all over face and body that resembles measles (small red dots approx 250 of them). Day three the fever is gone but rash is still present. Child has had no appetite for 3 days.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Convulsion, Erythema, Skin striae, Syncope
Clinical narrative: Fainted, seizure (10 seconds), red stripe from palm to elbow joint on the anterior left forearm. (same side as immunization was administered.) EMT called and did an assessment. She declined further assessment at the ER. Instructed to go to ER if any symptoms reoccur and to follow up with an appointment with her primary care physician. Observed for 15 minutes upon recovery and instructed to continue on light duty with continued observation by coworker.
Age: 65.0
Sex: F
Vaccine: MEA
Symptoms: Arthralgia, Musculoskeletal pain
Clinical narrative: Upon awakening the morning after shot was administered, pt experience significant bilateral shoulder and knee joint pain. Pt cites she has never experience arthralgias in the past.
Age: 36.0
Sex: M
Vaccine: FLU3
Symptoms: Abdominal distension, Cardiac arrest, Death, Depressed level of consciousness, Dyspnoea
Clinical narrative: 12/16/2010.  Patient's wife called to report that he developed nausea, headache, sweats, aching, cold two days ago (1 day after the flu vaccine was administered). On 12/15/10 he had more difficulty breathing but didn't mention this on 12/16/10 although he still had body aches.  I recommended that he receive ibuprofen 800 mg tid until the symptoms subsided.  Go to ER for increased difficulty breathing. 12/20/10.  Hospital ED physician called to report that patient was found by his wife in the morning to be difficult to arouse.  His abdomen was distended and he had nausea with increased secretions.  911 was called.  They found his pulse to be thready and while being transported to the ER went into ventricular fibrillation and then asystole.  A full code was done in the ER but they were unable to resuscitate him and he died.
Age: 36.0
Sex: M
Vaccine: FLU3
Symptoms: Headache, Hyperhidrosis, Increased bronchial secretion, Nasopharyngitis, Nausea
Clinical narrative: 12/16/2010.  Patient's wife called to report that he developed nausea, headache, sweats, aching, cold two days ago (1 day after the flu vaccine was administered). On 12/15/10 he had more difficulty breathing but didn't mention this on 12/16/10 although he still had body aches.  I recommended that he receive ibuprofen 800 mg tid until the symptoms subsided.  Go to ER for increased difficulty breathing. 12/20/10.  Hospital ED physician called to report that patient was found by his wife in the morning to be difficult to arouse.  His abdomen was distended and he had nausea with increased secretions.  911 was called.  They found his pulse to be thready and while being transported to the ER went into ventricular fibrillation and then asystole.  A full code was done in the ER but they were unable to resuscitate him and he died.
Age: 36.0
Sex: M
Vaccine: FLU3
Symptoms: Pain, Pulse abnormal, Resuscitation, Ventricular fibrillation
Clinical narrative: 12/16/2010.  Patient's wife called to report that he developed nausea, headache, sweats, aching, cold two days ago (1 day after the flu vaccine was administered). On 12/15/10 he had more difficulty breathing but didn't mention this on 12/16/10 although he still had body aches.  I recommended that he receive ibuprofen 800 mg tid until the symptoms subsided.  Go to ER for increased difficulty breathing. 12/20/10.  Hospital ED physician called to report that patient was found by his wife in the morning to be difficult to arouse.  His abdomen was distended and he had nausea with increased secretions.  911 was called.  They found his pulse to be thready and while being transported to the ER went into ventricular fibrillation and then asystole.  A full code was done in the ER but they were unable to resuscitate him and he died.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abdominal distension, Abdominal pain, Alopecia, Antinuclear antibody positive, Band neutrophil count increased
Clinical narrative: SECOND INJECTION OF GARDASIL- FATIGUE, POLYDIPSIA, COLD EXTREMITIES, CHEST DISCOMFORT, TINNITUS, HEADACHES, MUSCLE PAIN AND WEAKNESS, SEVERE ABDOMINAL PAIN, BLOATING, SLEEP TROUBLE, IMPAIRED CONCENTRATION, CHILLS, HAIR FALLING OUT IN CLUMPS.  THIRD INJECTION- SAME SYMPTOMS AS ABOVE WITH INCREASE IN INTENSITY AND DISCOMFORT.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Chest discomfort, Chills, Differential white blood cell count abnormal, Disturbance in attention, Fatigue
Clinical narrative: SECOND INJECTION OF GARDASIL- FATIGUE, POLYDIPSIA, COLD EXTREMITIES, CHEST DISCOMFORT, TINNITUS, HEADACHES, MUSCLE PAIN AND WEAKNESS, SEVERE ABDOMINAL PAIN, BLOATING, SLEEP TROUBLE, IMPAIRED CONCENTRATION, CHILLS, HAIR FALLING OUT IN CLUMPS.  THIRD INJECTION- SAME SYMPTOMS AS ABOVE WITH INCREASE IN INTENSITY AND DISCOMFORT.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Headache, Insomnia, Muscular weakness, Myalgia, Peripheral coldness
Clinical narrative: SECOND INJECTION OF GARDASIL- FATIGUE, POLYDIPSIA, COLD EXTREMITIES, CHEST DISCOMFORT, TINNITUS, HEADACHES, MUSCLE PAIN AND WEAKNESS, SEVERE ABDOMINAL PAIN, BLOATING, SLEEP TROUBLE, IMPAIRED CONCENTRATION, CHILLS, HAIR FALLING OUT IN CLUMPS.  THIRD INJECTION- SAME SYMPTOMS AS ABOVE WITH INCREASE IN INTENSITY AND DISCOMFORT.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Polydipsia, Postural orthostatic tachycardia syndrome, Similar reaction on previous exposure to drug, Tinnitus
Clinical narrative: SECOND INJECTION OF GARDASIL- FATIGUE, POLYDIPSIA, COLD EXTREMITIES, CHEST DISCOMFORT, TINNITUS, HEADACHES, MUSCLE PAIN AND WEAKNESS, SEVERE ABDOMINAL PAIN, BLOATING, SLEEP TROUBLE, IMPAIRED CONCENTRATION, CHILLS, HAIR FALLING OUT IN CLUMPS.  THIRD INJECTION- SAME SYMPTOMS AS ABOVE WITH INCREASE IN INTENSITY AND DISCOMFORT.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abdominal distension, Abdominal pain, Abdominal pain upper, Acne, Alopecia
Clinical narrative: SECOND INJECTION OF GARDASIL- FATIGUE, POLYDIPSIA, COLD EXTREMITIES, CHEST DISCOMFORT, TINNITUS, HEADACHES, MUSCLE PAIN AND WEAKNESS, SEVERE ABDOMINAL PAIN, BLOATING, SLEEP TROUBLE, IMPAIRED CONCENTRATION, CHILLS, HAIR FALLING OUT IN CLUMPS.  THIRD INJECTION- SAME SYMPTOMS AS ABOVE WITH INCREASE IN INTENSITY AND DISCOMFORT.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Antinuclear antibody positive, Asthenia, Autoimmune disorder, Blister, Chest discomfort
Clinical narrative: SECOND INJECTION OF GARDASIL- FATIGUE, POLYDIPSIA, COLD EXTREMITIES, CHEST DISCOMFORT, TINNITUS, HEADACHES, MUSCLE PAIN AND WEAKNESS, SEVERE ABDOMINAL PAIN, BLOATING, SLEEP TROUBLE, IMPAIRED CONCENTRATION, CHILLS, HAIR FALLING OUT IN CLUMPS.  THIRD INJECTION- SAME SYMPTOMS AS ABOVE WITH INCREASE IN INTENSITY AND DISCOMFORT.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Chest pain, Chills, Condition aggravated, Culture negative, Diarrhoea
Clinical narrative: SECOND INJECTION OF GARDASIL- FATIGUE, POLYDIPSIA, COLD EXTREMITIES, CHEST DISCOMFORT, TINNITUS, HEADACHES, MUSCLE PAIN AND WEAKNESS, SEVERE ABDOMINAL PAIN, BLOATING, SLEEP TROUBLE, IMPAIRED CONCENTRATION, CHILLS, HAIR FALLING OUT IN CLUMPS.  THIRD INJECTION- SAME SYMPTOMS AS ABOVE WITH INCREASE IN INTENSITY AND DISCOMFORT.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Discomfort, Disturbance in attention, Dizziness, Dysmenorrhoea, Dyspnoea
Clinical narrative: SECOND INJECTION OF GARDASIL- FATIGUE, POLYDIPSIA, COLD EXTREMITIES, CHEST DISCOMFORT, TINNITUS, HEADACHES, MUSCLE PAIN AND WEAKNESS, SEVERE ABDOMINAL PAIN, BLOATING, SLEEP TROUBLE, IMPAIRED CONCENTRATION, CHILLS, HAIR FALLING OUT IN CLUMPS.  THIRD INJECTION- SAME SYMPTOMS AS ABOVE WITH INCREASE IN INTENSITY AND DISCOMFORT.
Age: 15.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Ear pain, Fatigue, Flatulence, Food craving, Headache
Clinical narrative: SECOND INJECTION OF GARDASIL- FATIGUE, POLYDIPSIA, COLD EXTREMITIES, CHEST DISCOMFORT, TINNITUS, HEADACHES, MUSCLE PAIN AND WEAKNESS, SEVERE ABDOMINAL PAIN, BLOATING, SLEEP TROUBLE, IMPAIRED CONCENTRATION, CHILLS, HAIR FALLING OUT IN CLUMPS.  THIRD INJECTION- SAME SYMPTOMS AS ABOVE WITH INCREASE IN INTENSITY AND DISCOMFORT.